말라리아 진단 시장 : 제품별, 기술별, 최종 용도별 - 세계 예측

Malaria diagnostics market size is projected to witness 5% CAGR from 2024 - 2032, driven by the increasing prevalence of malaria, particularly in sub-Saharan Africa, Southeast Asia, and parts of Latin America. As per WHO, in 2022, it is estimated that there were 249 million malaria cases and 608,000 malaria-related deaths worldwide. The demand for effective diagnostic tools stems from the necessity to promptly identify and treat malaria cases to prevent severe complications and reduce mortality rates. With the improving healthcare infrastructures, diagnostic technologies have become more accessible.

Innovations, such as rapid diagnostic tests RDTs, which provide quick and accurate results without the need for specialized equipment or electricity, have revolutionized malaria diagnosis in resource-limited settings. The development of molecular diagnostic methods, such as polymerase chain reaction PCR and loop-mediated isothermal amplification LAMP are also offering higher sensitivity and specificity in detecting malaria parasites, further driving the market growth.

The malaria diagnostics industry is classified into product, technology, end-use and region.

Based on product, the market value from the instrument segment is anticipated to observe a significant CAGR during 2024-2032 favored by the strong need for providing advanced and automated solutions that enhance the efficiency and accuracy of malaria testing. Instruments, such as automated microscopy systems, nucleic acid amplification analyzers, and high-throughput screening platforms streamline the diagnostic process while reducing turnaround times and improving throughput in laboratories and healthcare settings.

Malaria diagnostics market from the microscopy technology segment is set to witness notable growth through 2032 due to its established role as a reliable and widely used method for detecting malaria parasites. Microscopic examination of blood smears remains a cornerstone in malaria diagnosis for offering high specificity and the ability to identify different species of Plasmodium parasites. Rapid advancements in microscopy techniques, such as digital microscopy and automated image analysis systems to enhance the accuracy and efficiency of malaria diagnosis will also drive the segment growth.

Asia Pacific malaria diagnostics industry will showcase impressive growth over 2024-2032. Increased government initiatives and international funding aimed at malaria elimination and control programs will significantly boost the demand for accurate and rapid diagnostic methods. Additionally, the expansion of healthcare infrastructure and improvements in laboratory capabilities across the region are facilitating better access to advanced diagnostic technologies.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of malaria
    • 3.2.1.2 Advancement in diagnostic technologies
    • 3.2.1.3 Rising awareness and education regarding malaria prevention
    • 3.2.1.4 Increasing adoption of point-of-care testing in developing countries
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 Stringent regulatory scenario
• 3.3 Growth potential analysis
• 3.4 Technological landscape
• 3.5 Regulatory landscape
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company market share analysis
• 4.3 Competitive positioning matrix
• 4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Instruments
• 5.3 Kits & reagents

Chapter 6 Market Estimates and Forecast, By Technology, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Microscopy
• 6.3 Rapid diagnostic tests
• 6.4 Molecular diagnostic tests
  • 6.4.1 Conventional PCR
  • 6.4.2 Real-time PCR
• 6.5 Other technologies

Chapter 7 Market Estimates and Forecast, By End-Use, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Clinics
• 7.3 Hospitals
• 7.4 Diagnostic centers
• 7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Netherlands
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 Japan
  • 8.4.2 China
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Argentina
  • 8.5.4 Rest of Latin America
• 8.6 Middle East and Africa
  • 8.6.1 Saudi Arabia
  • 8.6.2 South Africa
  • 8.6.3 UAE
  • 8.6.4 Rest of Middle East and Africa

Chapter 9 Company Profiles

• 9.1 Abbott Laboratories
• 9.2 Access Bio
• 9.3 Becton, Dickinson and Company
• 9.4 Bio-Rad Laboratories, Inc.
• 9.5 Danaher corporation
• 9.6 F. Hoffmann-La Roche Ltd.
• 9.7 Nikon Corporation
• 9.8 Premier Medical Corporation Private Limited
• 9.9 Siemens Healthineers AG
• 9.10 Thermo Fisher Scientific Inc.